Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 221 resultados

GRASSHOPPER: The GRASSHOPPER network Jumping forward from preclinical development of pediatric cancer drugs to c... Every year 16.000 children in Europe are diagnosed with cancer, and 2000 children (approximately 70 school classes) die from this illness. N...
2024-10-24 - 2028-11-30 | Financiado

EASIGEN-DS: DESIGN STUDY FOR A EUROPEAN INFRASTRUCTURE ON ADVANCED GENOMICS TECHNOLOGIES DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG participó en un HORIZON EUROPE: HORIZON-INFRA-2024-DEV-01 Innovation in the genomics field is extremely intense and requires high up-front investments. The toolbox of sequencing platforms with uniqu...
2024-10-09 - 2028-01-31 | Financiado

CENTRIC-BRAIN: Characterizing and harnessing tumor-reactive T cells in the brain DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG tramitó un HORIZON EUROPE: ERC-2023-ADG Personalized tumor immunotherapy - vaccines and T cell therapies - requires the selection of few immunogenic epitopes recognized by tumor-re...
2024-10-01 - 2029-09-30 | Financiado

METABAC: Functional characterization of the colorectal cancer metastasis microbiome DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG tramitó un HORIZON EUROPE: ERC-2024-STG Host cells and microbial inhabitants form an intricate ecosystem in the human body, extensively influencing host phenotypes in health and di...
2024-09-20 - 2029-09-30 | Financiado

VIDA: VHIO International postDoctoral programme for translAtional research DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG participó en un HORIZON EUROPE: HORIZON-MSCA-2023-COFUND-01 The proposed VHIO International postDoctoral programme for translAtional research (VIDA) aims at enabling outstanding junior scientists of a...
2024-09-12 - 2029-12-31 | Financiado

VulnerableInhibition: Cognitive deficits resulting from selective vulnerability of septal inhibitory neurons: mitochondria... DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG tramitó un HORIZON EUROPE: ERC-2023-ADG Septal GABAergic projection neurons are considered “pacemaker” cells as they enable the temporal organization of neuronal spike firing in hi...
2024-09-01 - 2028-08-31 | Financiado

UPLIFT: UPright radiotherapy Learning Innovation Fellowship and Training Radiotherapy (RT) is a mainstay of modern cancer treatment. Conventionally, RT is delivered to the patient lying on a treatment couch, while...
2024-07-10 - 2028-09-30 | Financiado

CENTRIC-BRAIN: Characterizing and harnessing tumor reactive T cells in the brain DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG tramitó un HORIZON EUROPE: ERC-2023-ADG Personalized tumor immunotherapy - vaccines and T cell therapies - requires the selection of few immunogenic epitopes recognized by tumor-re...
2024-07-09 - 2029-09-30 | Financiado

MiCCrobioTAckle: Advancing Research at the Intersection Between Gut Microbiota and Cancer Cachexia to Train Europe s... DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG participó en un HORIZON EUROPE: HORIZON-MSCA-2023-DN-01 Microbiota medicine is the new frontier in human health. The human gastrointestinal tract is home to trillions of microbes. Under normal con...
2024-07-05 - 2028-10-31 | Financiado

VulnerableInhibition: Cognitive deficits resulting from selective vulnerability of septal inhibitory neurons mitochondria... DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG tramitó un HORIZON EUROPE: ERC-2023-ADG Septal GABAergic projection neurons are considered pacemaker cells as they enable the temporal organization of neuronal spike firing in hipp...
2024-06-02 - 2028-08-31 | Financiado

TimedEnhancer: Temporal dependence of enhancer function DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG tramitó un HORIZON EUROPE: ERC-2023-STG During vertebrate development, genes are regulated by distal regulatory elements, presumably via physical contacts between enhancers and tra...
2024-06-01 - 2029-05-31 | Financiado

MENTORING: Addressing malnutrition and metabolic health in non communicable diseases through precision Nutritio... Malnutrition represents a major burden for a large part of the population and, in particular, for vulnerable population groups like lung can...
2024-05-31 - 2028-08-31 | Financiado

Cancer-Harakiri: Targeting the undruggable: Leveraging neomorphic DNA-binding preferences of chimeric fusion oncogene... DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG tramitó un HORIZON EUROPE: ERC-2023-COG Many aggressive cancers, such as pediatric high-risk Ewing sarcoma and alveolar rhabdomyosarcoma, are fueled by and addicted to chimeric onc...
2024-01-01 - 2028-12-31 | Financiado

4D-therapy: Multimodal “4D”-therapy of pediatric high grade glioma DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG tramitó un HORIZON EUROPE: ERC-2023-STG Paediatric high grade glioma (pHGG) is the most common malignant childhood brain tumour with standard-of-care inevitably resulting in therap...
2024-01-01 - 2028-12-31 | Financiado

BEHIND-MS: The role of an Epstein-Barr virus infection in the pathogenesis of multiple sclerosis DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-03 Multiple Sclerosis (MS) is the most frequent neuroinflammatory disease. Despite new treatments that slow the progression of the disease, pat...
2023-12-01 - 2028-11-30 | Financiado

MRDAML: Deciphering the mechanistic basis of minimal residual disease and treatment resistance in acute myel... DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-PF-01 Acute myeloid leukemia (AML) is one of the most aggressive and deadliest cancers with frequent relapse. Although initial therapies eliminate...
2023-09-01 - 2025-08-31 | Financiado

SpatialTMEMetabolism: Spatial Quantification of Cellular Metabolism in the Tumor Immune Microenvironment DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG tramitó un HORIZON EUROPE: ERC-2023-STG The success of cancer immunotherapy, especially immune checkpoint inhibition (ICI), demonstrates the ability of the immune system to fight t...
2023-09-01 - 2028-08-31 | Financiado

GERMAN CANCER RESEARCH CENTER